Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

[Polycystic kidney disease: 10 key messages].

Thervet É.

Rev Prat. 2018 May;68(5):570. French. No abstract available.

PMID:
30869432
2.

Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Yoshida K, Takahashi N, King BF, Kawashima A, Harris PC, Cornell LD, Cornec-Le Gall E, Inoue D, Mizushima I, Kawano M, Thervet E, de Cotret PR, Torres VE.

Eur Radiol. 2019 Feb 26. doi: 10.1007/s00330-019-06057-3. [Epub ahead of print]

PMID:
30806804
3.

[Acute renal failure of glomerular origin].

Thervet É.

Rev Prat. 2018 Feb;68(2):160-165. French.

PMID:
30801142
4.

Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.

Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP; NephroTest Study Group.

Am J Kidney Dis. 2019 May;73(5):596-604. doi: 10.1053/j.ajkd.2018.12.024. Epub 2019 Feb 15.

PMID:
30777634
5.

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.

Vidal-Petiot E, Metzger M, Faucon AL, Boffa JJ, Haymann JP, Thervet E, Houillier P, Geri G, Stengel B, Vrtovsnik F, Flamant M; NephroTest study group.

J Am Heart Assoc. 2018 Oct 2;7(19):e010278. doi: 10.1161/JAHA.118.010278.

6.

[Immunizations for patients with kidney disease].

Trivin-Avillach C, Thervet É.

Nephrol Ther. 2019 Jul;15(4):233-240. doi: 10.1016/j.nephro.2017.11.007. Epub 2018 Jun 19. French.

PMID:
29887267
7.

Relevance of urinary specific protein assay in the diagnosis of kidney diseases.

Flahault A, Chassé JF, Thervet E, Karras A, Pallet N.

Ann Biol Clin (Paris). 2018 Jun 1;76(3):259-269. doi: 10.1684/abc.2018.1343.

PMID:
29862969
8.

Porphyria and kidney diseases.

Pallet N, Karras A, Thervet E, Gouya L, Karim Z, Puy H.

Clin Kidney J. 2018 Apr;11(2):191-197. doi: 10.1093/ckj/sfx146. Epub 2018 Jan 10.

9.

Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.

Maunoury F, Clément A, Nwankwo C, Levy-Bachelot L, Abergel A, Di Martino V, Thervet E, Durand-Zaleski I.

PLoS One. 2018 Mar 15;13(3):e0194329. doi: 10.1371/journal.pone.0194329. eCollection 2018.

10.

Association of a Low-Protein Diet With Slower Progression of CKD.

Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B.

Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.

11.

Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.

Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.

Pharmacol Res. 2018 Mar;129:84-94. doi: 10.1016/j.phrs.2017.12.005. Epub 2017 Dec 8.

PMID:
29229354
12.

Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis.

Henique C, Bollée G, Loyer X, Grahammer F, Dhaun N, Camus M, Vernerey J, Guyonnet L, Gaillard F, Lazareth H, Meyer C, Bensaada I, Legrès L, Satoh T, Akira S, Bruneval P, Dimmeler S, Tedgui A, Karras A, Thervet E, Nochy D, Huber TB, Mesnard L, Lenoir O, Tharaux PL.

Nat Commun. 2017 Nov 28;8(1):1829. doi: 10.1038/s41467-017-01885-7.

13.

Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKD.

Liabeuf S, Ryckelynck JP, El Esper N, Ureña P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prié D, Choukroun G; FRENCH Study collaborators.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1930-1940. doi: 10.2215/CJN.03030317. Epub 2017 Oct 26.

14.

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Oct 6;18(1):308. doi: 10.1186/s12882-017-0723-2. No abstract available.

15.

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Sep 12;18(1):295. doi: 10.1186/s12882-017-0710-7. Erratum in: BMC Nephrol. 2017 Oct 6;18(1):308.

16.

Prevention and treatment of diabetic nephropathy

Thervet É.

Rev Prat. 2017 Sep;67(7):708-712. French. No abstract available.

PMID:
30512760
17.

Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease.

Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A.

Clin Kidney J. 2017 Aug;10(4):461-469. doi: 10.1093/ckj/sfw101. Epub 2016 Nov 10.

18.

Diagnosis of congenital toxoplasmosis in a renal transplant recipient mother.

Hermann M, Yéra H, Villena I, Cimon B, Thervet E, Benachi A.

J Gynecol Obstet Hum Reprod. 2017 Oct;46(8):661-663. doi: 10.1016/j.jogoh.2017.08.004. Epub 2017 Aug 26.

PMID:
28851620
19.

Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.

Kormann R, Jannot AS, Narjoz C, Ribeil JA, Manceau S, Delville M, Joste V, Prié D, Pouchot J, Thervet E, Courbebaisse M, Arlet JB.

Br J Haematol. 2017 Oct;179(2):323-335. doi: 10.1111/bjh.14842. Epub 2017 Jul 12.

PMID:
28699644
20.

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases.

Golbin L, Vigneau C, Touchard G, Thervet E, Halimi JM, Sawadogo T, Lagoutte N, Siohan P, Zagdoun E, Hertig A, Rioux-Leclercq N, Frouget T.

Clin Kidney J. 2017 Jun;10(3):381-388. doi: 10.1093/ckj/sfw133. Epub 2017 Feb 8.

21.

Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey.

Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, Cacoub P, Jourde-Chiche N, Urbanski G, Augusto JF, Moulis G, Raffray L, Deroux A, Hummel A, Lioger B, Catroux M, Faguer S, Goutte J, Martis N, Maurier F, Rivière E, Sanges S, Baldolli A, Costedoat-Chalumeau N, Roriz M, Puéchal X, André M, Lavigne C, Bienvenu B, Mekinian A, Zagdoun E, Girard C, Bérezné A, Guillevin L, Thervet E, Pillebout E; French Vasculitis Study Group.

Arthritis Rheumatol. 2017 Sep;69(9):1862-1870. doi: 10.1002/art.40178.

22.

Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports.

Chavarot N, Lebbe C, Thervet E, Bouscary D, Karras A.

Acta Derm Venereol. 2017 Oct 2;97(9):1138-1139. doi: 10.2340/00015555-2727.

23.

The Diagnosis-Wide Landscape of Hospital-Acquired AKI.

Jannot AS, Burgun A, Thervet E, Pallet N.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):874-884. doi: 10.2215/CJN.10981016. Epub 2017 May 11.

24.

A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease.

Tchernitchko D, Tavernier Q, Lamoril J, Schmitt C, Talbi N, Lyoumi S, Robreau AM, Karim Z, Gouya L, Thervet E, Karras A, Puy H, Pallet N.

J Am Soc Nephrol. 2017 Jun;28(6):1924-1932. doi: 10.1681/ASN.2016080918. Epub 2016 Dec 28.

25.

Clinical impact of the CYP3A5 6986A>G allelic variant on kidney transplantation outcomes.

Flahault A, Anglicheau D, Loriot MA, Thervet E, Pallet N.

Pharmacogenomics. 2017 Jan;18(2):165-173. doi: 10.2217/pgs-2016-0146. Epub 2016 Dec 15.

PMID:
27977332
26.

A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.

Jasiek M, Karras A, Le Guern V, Krastinova E, Mesbah R, Faguer S, Jourde-Chiche N, Fauchais AL, Chiche L, Dernis E, Moulis G, Fraison JB, Lazaro E, Jullien P, Hachulla E, Le Quellec A, Rémy P, Hummel A, Costedoat-Chalumeau N, Ronco P, Vanhille P, Meas-Yedid V, Cordonnier C, Ferlicot S, Daniel L, Seror R, Mariette X, Thervet E, François H, Terrier B.

Rheumatology (Oxford). 2017 Mar 1;56(3):362-370. doi: 10.1093/rheumatology/kew376.

27.

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

Gatault P, Kamar N, Büchler M, Colosio C, Bertrand D, Durrbach A, Albano L, Rivalan J, Le Meur Y, Essig M, Bouvier N, Legendre C, Moulin B, Heng AE, Weestel PF, Sayegh J, Charpentier B, Rostaing L, Thervet E, Lebranchu Y.

Am J Transplant. 2017 May;17(5):1370-1379. doi: 10.1111/ajt.14109. Epub 2017 Jan 3.

28.

Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.

Luck M, Bertho G, Bateson M, Karras A, Yartseva A, Thervet E, Damon C, Pallet N.

PLoS One. 2016 Nov 18;11(11):e0166905. doi: 10.1371/journal.pone.0166905. eCollection 2016.

29.

French law: what about a reasoned reimbursement of serum vitamin D assays?

Souberbielle JC, Benhamou CL, Cortet B, Rousière M, Roux C, Abitbol V, Annweiler C, Audran M, Bacchetta J, Bataille P, Beauchet O, Bardet R, Benachi A, Berenbaum F, Blain H, Borson-Chazot F, Breuil V, Briot K, Brunet P, Carel JC, Caron P, Chabre O, Chanson P, Chapurlat R, Cochat P, Coutant R, Christin-Maitre S, Cohen-Solal M, Combe C, Cormier C, Courbebaisse M, Debrus G, Delemer B, Deschenes G, Duquenne M, Duval G, Fardellone P, Fouque D, Friedlander G, Gauvain JB, Groussin L, Guggenbuhl P, Houillier P, Hannedouche T, Jacot W, Javier RM, Jean G, Jeandel C, Joly D, Kamenicky P, Knebelmann B, Lafage-Proust MH, LeBouc Y, Legrand E, Levy-Weil F, Linglart A, Machet L, Maheu E, Mallet E, Marcelli C, Marès P, Mariat C, Maruani G, Maugars Y, Montagnon F, Moulin B, Orcel P, Partouche H, Personne V, Pierrot-Deseilligny C, Polak M, Pouteil-Noble C, Prié D, Raynaud-Simon A, Rolland Y, Sadoul JL, Salle B, Sault C, Schott AM, Sermet-Gaudelus I, Soubrier M, Tack I, Thervet E, Tostivint I, Touraine P, Tremollières F, Urena-Torres P, Viard JP, Wemeau JL, Weryha G, Winer N, Young J, Thomas T.

Geriatr Psychol Neuropsychiatr Vieil. 2016 Dec 1;14(4):377-382. Review.

PMID:
27818369
30.

Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.

31.

Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.

Cassuto E, Pageaux GP, Cantarovich D, Rostaing L, Loupy A, Roche B, Duvoux C, Moreau K, Thervet E, Mazouz H, Bourhis Y, Dharancy S, Kessler M; OSIRIS investigators.

Transplantation. 2016 Oct;100(10):2099-2106. Erratum in: Transplantation. 2017 Jan;101(1):e40-e41.

PMID:
27653227
32.

Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.

Damon C, Luck M, Toullec L, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Thierry A, Vigneau C, Moulin B, Heng AE, Subra JF, Legendre C, Monnot A, Yartseva A, Bateson M, Laurent-Puig P, Anglicheau D, Beaune P, Loriot MA, Thervet E, Pallet N.

Am J Transplant. 2017 Apr;17(4):1008-1019. doi: 10.1111/ajt.14040. Epub 2016 Oct 7.

33.

[PATHOPHYSIOLOGY OF CARDIORENAL SYNDROME].

Thervet É.

Rev Prat. 2016 Jun;66(6):611-5. French.

PMID:
27538312
34.

SYNDROMES CARDIO-RÉNAUX.

Thervet É.

Rev Prat. 2016 Jun;66(6):607. French. No abstract available.

PMID:
27538310
35.

Urinary Angiogenin Reflects the Magnitude of Kidney Injury at the Infrahistologic Level.

Tavernier Q, Mami I, Rabant M, Karras A, Laurent-Puig P, Chevet E, Thervet E, Anglicheau D, Pallet N.

J Am Soc Nephrol. 2017 Feb;28(2):678-690. doi: 10.1681/ASN.2016020218. Epub 2016 Jul 19.

36.

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.

Flahault A, Metzger M, Chassé JF, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E, Pallet N; NephroTest study group.

PLoS One. 2016 Jun 1;11(6):e0156433. doi: 10.1371/journal.pone.0156433. eCollection 2016.

37.

Quiz Page April 2016: A 59-Year-Old Man With Hypercalcemia and Acute Kidney Injury.

Cohen C, Thervet E, Nochy D, Karras A.

Am J Kidney Dis. 2016 Apr;67(4):A17-9. doi: 10.1053/j.ajkd.2015.11.027. No abstract available.

PMID:
27012947
38.

Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype.

Pallet N, Etienne I, Buchler M, Bailly E, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Legendre C, Beaune P, Loriot MA, Thervet E.

Am J Transplant. 2016 Sep;16(9):2670-5. doi: 10.1111/ajt.13788. Epub 2016 Apr 8.

39.

[Applied pharmacogenetic].

Thervet É.

Nephrol Ther. 2016 Apr;12 Suppl 1:S99-S103. doi: 10.1016/j.nephro.2016.02.008. Epub 2016 Mar 10. French.

PMID:
26972091
40.

A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients.

Jannot AS, Vuillemin X, Etienne I, Buchler M, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Rerolle JP, Heng AE, Subra JF, Legendre C, Beaune P, Loriot MA, Thervet E, Pallet N.

Ther Drug Monit. 2016 Apr;38(2):223-9. doi: 10.1097/FTD.0000000000000267.

PMID:
26829596
41.

A Novel Extrinsic Pathway for the Unfolded Protein Response in the Kidney.

Mami I, Tavernier Q, Bouvier N, Aboukamis R, Desbuissons G, Rabant M, Poindessous V, Laurent-Puig P, Beaune P, Tharaux PL, Thervet E, Chevet E, Anglicheau D, Pallet N.

J Am Soc Nephrol. 2016 Sep;27(9):2670-83. doi: 10.1681/ASN.2015060703. Epub 2016 Jan 28.

42.

The Case | A man with hypertension, respiratory distress, and rapidly progressive renal failure.

Zaidan M, Koumakis E, Karras A, Bruneval P, Thervet E, Nochy D.

Kidney Int. 2016 Feb;89(2):509-10. doi: 10.1016/j.kint.2015.12.014. No abstract available.

PMID:
26806839
43.

Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.

Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, Rivalan J, Thervet E, Essig M, Babinet F, Subra JF, Toubas O, Rieu P, Launois C, Perotin-Collard JM, Lebargy F, Deslée G; Spiesser group.

BMC Pulm Med. 2015 Nov 7;15:141. doi: 10.1186/s12890-015-0133-9.

44.

Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.

Luque Y, Jamme M, Rabant M, DeWolf S, Noël LH, Thervet E, Chatenoud L, Snanoudj R, Anglicheau D, Legendre C, Candon S, Zuber J.

Nephrol Dial Transplant. 2016 Mar;31(3):487-95. doi: 10.1093/ndt/gfv362. Epub 2015 Oct 22.

PMID:
26492923
45.

Angiogenin Mediates Cell-Autonomous Translational Control under Endoplasmic Reticulum Stress and Attenuates Kidney Injury.

Mami I, Bouvier N, El Karoui K, Gallazzini M, Rabant M, Laurent-Puig P, Li S, Tharaux PL, Beaune P, Thervet E, Chevet E, Hu GF, Pallet N.

J Am Soc Nephrol. 2016 Mar;27(3):863-76. doi: 10.1681/ASN.2015020196. Epub 2015 Jul 20.

46.

Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN.

Henique C, Bollee G, Lenoir O, Dhaun N, Camus M, Chipont A, Flosseau K, Mandet C, Yamamoto M, Karras A, Thervet E, Bruneval P, Nochy D, Mesnard L, Tharaux PL.

J Am Soc Nephrol. 2016 Jan;27(1):172-88. doi: 10.1681/ASN.2014111080. Epub 2015 May 21.

47.

[Spot urinary protein to creatinine ratio: Which role in preeclampsia diagnosis?].

Bejjani L, Nedellec S, Taïeb J, Thervet E, Benachi A.

J Gynecol Obstet Biol Reprod (Paris). 2015 Nov;44(9):795-801. doi: 10.1016/j.jgyn.2015.04.006. Epub 2015 May 13. Review. French.

48.

Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.

Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E; NephroTest Study Group.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):957-64. doi: 10.2215/CJN.08540814. Epub 2015 May 15.

49.

High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria.

Pallet N, Mami I, Schmitt C, Karim Z, François A, Rabant M, Nochy D, Gouya L, Deybach JC, Xu-Dubois Y, Thervet E, Puy H, Karras A.

Kidney Int. 2015 Aug;88(2):386-95. doi: 10.1038/ki.2015.97. Epub 2015 Apr 1.

PMID:
25830761
50.

Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2015 Aug;30(8):1386-94. doi: 10.1093/ndt/gfv047. Epub 2015 Mar 27.

PMID:
25817225

Supplemental Content

Loading ...
Support Center